Catherine Wheeler

4.6k total citations
73 papers, 3.6k citations indexed

About

Catherine Wheeler is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Catherine Wheeler has authored 73 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 31 papers in Molecular Biology and 21 papers in Hematology. Recurrent topics in Catherine Wheeler's work include Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (13 papers) and Histone Deacetylase Inhibitors Research (10 papers). Catherine Wheeler is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (13 papers) and Histone Deacetylase Inhibitors Research (10 papers). Catherine Wheeler collaborates with scholars based in United States, United Kingdom and Japan. Catherine Wheeler's co-authors include Anthony Elias, Lois Ayash, Karen H. Antman, Lowell E. Schnipper, Alan Barge, Joseph H. Antin, Paul G. Richardson, M Hunt, Joseph P. Eder and Gary N. Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Catherine Wheeler

71 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Catherine Wheeler 1.7k 1.1k 1.1k 655 520 73 3.6k
Albrecht Reichle 1.8k 1.0× 1.0k 0.9× 1.4k 1.2× 657 1.0× 214 0.4× 125 3.8k
F. Cavalli 2.2k 1.3× 705 0.6× 369 0.3× 1.5k 2.2× 660 1.3× 147 4.0k
Gordan Srkalović 1.8k 1.0× 1.6k 1.4× 1.3k 1.2× 167 0.3× 389 0.7× 91 3.6k
Dennis F. Moore 2.1k 1.2× 1.5k 1.3× 741 0.7× 698 1.1× 1.3k 2.6× 101 4.5k
Marco Danova 1.6k 0.9× 1.1k 1.0× 553 0.5× 338 0.5× 576 1.1× 226 3.5k
Marek Z. Wojtukiewicz 2.2k 1.3× 1.0k 0.9× 996 0.9× 342 0.5× 809 1.6× 190 4.5k
Gwen Nichols 1.1k 0.6× 1.1k 1.0× 504 0.5× 271 0.4× 325 0.6× 63 2.4k
Gary N. Schwartz 1.3k 0.7× 944 0.8× 357 0.3× 470 0.7× 1.0k 1.9× 89 3.7k
David T. Yang 768 0.4× 1.0k 0.9× 354 0.3× 653 1.0× 224 0.4× 91 2.7k
Rafael Santana-Dávila 1.7k 1.0× 1.7k 1.5× 730 0.7× 283 0.4× 1.2k 2.2× 70 3.7k

Countries citing papers authored by Catherine Wheeler

Since Specialization
Citations

This map shows the geographic impact of Catherine Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Wheeler more than expected).

Fields of papers citing papers by Catherine Wheeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Wheeler. The network helps show where Catherine Wheeler may publish in the future.

Co-authorship network of co-authors of Catherine Wheeler

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Wheeler. A scholar is included among the top collaborators of Catherine Wheeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Wheeler. Catherine Wheeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berdeja, Jesús G., Min Yang, Noopur Raje, et al.. (2024). Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Carolina Digital Repository (University of North Carolina at Chapel Hill).
2.
Jankú, Filip, Milind Javle, Shiraj Sen, et al.. (2023). A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors. Cancer. 129(10). 1537–1546. 1 indexed citations
3.
Wheeler, Catherine, et al.. (2013). Development and Pilot Outcome Data of a Midlife Women's Health Assessment Clinic: A Comprehensive and Multidisciplinary Approach to Health Care. Journal of Midwifery & Women s Health. 58(3). 328–332. 1 indexed citations
4.
Beerepoot, Laurens V., Sandra A. Radema, Els O. Witteveen, et al.. (2006). Phase I Clinical Evaluation of Weekly Administration of the Novel Vascular-Targeting Agent, ZD6126, in Patients With Solid Tumors. Journal of Clinical Oncology. 24(10). 1491–1498. 89 indexed citations
5.
Stone, Andrew, Catherine Wheeler, & Alan Barge. (2006). Improving the design of phase II trials of cytostatic anticancer agents. Contemporary Clinical Trials. 28(2). 138–145. 31 indexed citations
6.
Stone, Andrew, Catherine Wheeler, Kevin Carroll, & Alan Barge. (2006). Optimizing randomized phase II trials assessing tumor progression. Contemporary Clinical Trials. 28(2). 146–152. 19 indexed citations
7.
Holden, Scott N., Sabine Eckhardt, R. Basser, et al.. (2005). Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Annals of Oncology. 16(8). 1391–1397. 247 indexed citations
8.
9.
Frei, E, Gulshan Ara, Beverly A. Teicher, et al.. (2000). Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence. Cancer Chemotherapy and Pharmacology. 45(3). 239–246. 6 indexed citations
10.
Avigan, David, Paul G. Richardson, Anthony Elias, et al.. (1998). Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors. Cancer. 83(3). 409–414. 28 indexed citations
11.
Ayash, Lois, Anthony Elias, Joseph G. Ibrahim, et al.. (1998). High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.. Journal of Clinical Oncology. 16(3). 1000–1007. 50 indexed citations
12.
Churchill, W. H., Colin A. Sieff, Lawrence N. Shulman, et al.. (1995). The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high‐dose chemotherapy support. Transfusion. 35(10). 837–844. 7 indexed citations
13.
Wright, Joel E., Anthony Elias, Sylvia A. Holden, et al.. (1995). High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity. Cancer Chemotherapy and Pharmacology. 36(4). 345–351. 24 indexed citations
14.
Ayash, Lois, Anthony Elias, M Hunt, et al.. (1994). Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. British Journal of Haematology. 87(1). 153–161. 22 indexed citations
15.
Ayash, Lois, Anthony Elias, Catherine Wheeler, et al.. (1994). Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.. Journal of Clinical Oncology. 12(1). 37–44. 117 indexed citations
16.
Guinan, Eva C., Deborah C. Molrine, Joseph H. Antin, et al.. (1994). POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1. Transplantation. 57(5). 677–684. 89 indexed citations
17.
Ayash, Lois, Anthony Elias, Catherine Wheeler, et al.. (1993). High-Dose Chemotherapy with Autologous Stem Cell Support for Breast Cancer: A Review of the Dana-Farber Cancer Institute/Beth Israel Hospital Experience. Journal of Hematotherapy. 2(4). 507–511. 3 indexed citations
18.
Wheeler, Catherine, Myla Strawderman, Lois Ayash, et al.. (1993). Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.. Journal of Clinical Oncology. 11(6). 1085–1091. 58 indexed citations
19.
Wheeler, Catherine, Lawrence N. Shulman, Steven E. Come, Lowell E. Schnipper, & Thomas J. Ervin. (1991). Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung. Cancer. 67(4). 892–895. 4 indexed citations
20.
Wheeler, Catherine, et al.. (1974). Toxic and immunological properties of stinging coral toxin. Toxicon. 12(5). 487–490. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albrecht Reichle Breakdown of academic impact, for papers by F. Cavalli Breakdown of academic impact, for papers by Gordan Srkalović Breakdown of academic impact, for papers by Dennis F. Moore Breakdown of academic impact, for papers by Marco Danova Breakdown of academic impact, for papers by Marek Z. Wojtukiewicz Breakdown of academic impact, for papers by Gwen Nichols Breakdown of academic impact, for papers by Gary N. Schwartz Breakdown of academic impact, for papers by David T. Yang Breakdown of academic impact, for papers by Rafael Santana-Dávila
Rankless by CCL
2026